eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Bausch+Lomb - Comment

Bausch+Lomb - Comment

Document ID: FDA-2010-D-0283-0008
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: September 20 2010, at 12:00 AM Eastern Daylight Time
Date Posted: October 4 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: June 25 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: September 23 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80b5321f
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

Bausch+Lomb - Comment

Title:
Bausch+Lomb - Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 27
AstraZeneca - Comment
Public Submission    Posted: 10/04/2010     ID: FDA-2010-D-0283-0004

Sep 23,2010 11:59 PM ET
Sepracor Inc. - Comment
Public Submission    Posted: 10/04/2010     ID: FDA-2010-D-0283-0005

Sep 23,2010 11:59 PM ET
SOCMA Bulk Pharmaceutical Task Force - Comment
Public Submission    Posted: 10/04/2010     ID: FDA-2010-D-0283-0006

Sep 23,2010 11:59 PM ET
Abbott - Comment
Public Submission    Posted: 10/04/2010     ID: FDA-2010-D-0283-0007

Sep 23,2010 11:59 PM ET
Bausch+Lomb - Comment
Public Submission    Posted: 10/04/2010     ID: FDA-2010-D-0283-0008

Sep 23,2010 11:59 PM ET